Active Glycolytic Metabolism in CD133(+) Hepatocellular Cancer Stem Cells: Regulation by MIR-122

Oncotarget - United States
doi 10.18632/oncotarget.5812
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells Through Regulating the Tumor Metabolism

PLoS ONE
Multidisciplinary
2016English

miRNA122a Regulation of Gene Therapy Vectors Targeting Hepatocellular Cancer Stem Cells

Oncotarget
Oncology
2018English

Volume-Activated Chloride Channel Exists in CD133+ Lung Cancer Stem Cells

Journal of Cardiothoracic Surgery
CardiologyCardiovascular MedicineMedicinePulmonaryRespiratory MedicineSurgery
2013English

CD133 in Breast Cancer Cells: More Than a Stem Cell Marker

Journal of Oncology
Oncology
2019English

Cd133/Epcam Cancer Stem Cell Markers of Tumour Stage in Colorectal Cancer Cells

Journal of Tissue Science & Engineering
2015English

Redox Regulation in Cancer Stem Cells

Oxidative Medicine and Cellular Longevity
BiochemistryMedicineCell BiologyAging
2015English

Isolation of Cancer Stem Cells by Selection for miR-302 Expressing Cells

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2019English

miR-122 Regulates Hepatic Lipid Metabolism and Tumor Suppression

Journal of Clinical Investigation
Medicine
2012English

Cited2 Is Required for the Maintenance of Glycolytic Metabolism in Adult Hematopoietic Stem Cells

Stem Cells and Development
Developmental BiologyHematologyCell Biology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy